|By PR Newswire||
|February 10, 2014 03:00 PM EST||
DUBLIN, February 10, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/7rkbj7/pharmaceutical) has announced the addition of the"Pharmaceutical Excipients Market by Products & Functionality - Global Forecast to 2018" report to their offering.
The global market is segmented by product, functionality, and geography. By product, the pharmaceutical excipients market is broadly classified into organic chemicals, inorganic chemicals, and others. The organic chemicals market is further segmented as carbohydrates, proteins, oleochemicals and petrochemicals, and other organic chemicals. The inorganic chemicals market covers calcium products, halites, metal oxides, and other inorganic materials. The other products mainly include the USP water for pharmaceutical use. By functionality, the pharmaceutical excipients market is classified into fillers and diluents, binders, suspension and viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants and glidants, preservatives, and other applications.
The total market is further divided into four major geographies, namely, North America, Europe, Asia, and the Rest of the World (RoW). These regions are further analyzed at the country level. North America contributes the largest share to the global market, followed by Europe, Asia-Pacific, and the Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The shift of focus of the pharmaceutical industries towards Asia and the high import of generics from emerging markets are hindering the growth of these geographies. China, India, and Japan are likely to drive the growth of the Asian market. A majority of the growth in these markets is driven by increase in outsourcing to these locations mainly due to low-labor costs. These are also some of the most lucrative markets for manufacturing of generic drugs for the global market.
The global market is estimated to be worth $5,716 Million in 2013. The market is mainly driven by the increasing demand for functional excipients from the pharmaceutical industry. The rapid increase in the generics market due to patent expiration of many blockbuster drugs is expected to drive the sales of excipients in the forecast period. However, increasing quality compliance and regulatory requirements for excipient manufacturers in order to ensure more transparency in supply chain may inhibit the growth of the market to a certain extent.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF (Germany), Dow Chemical Company (U.S.), Roquette (France), FMC Corporation (U.S.), Evonik (Germany), ABF (U.K.), ADM (U.S.), Lubrizol (U.S.), and Croda (U.K.). Some of the players that have strong market shares in particular segments are JRS Pharma (Germany), DFE Fonterra (Germany), Meggle (Germany), Colorcon (U.S.), Aventor (U.S.), Cargill (U.S.), and Budenheim (Germany).
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Global Pharmaceutical Excipients Market, By Product
6 Global Pharmaceutical Excipients Market, By Functionality
7 Geographic Analysis
8 Competitive Landscape
- Archer Daniels Midland Company
- Ashland Inc
- Associated British Foods Plc
- Avantor Performance Materials, Inc
- Basf Se
- Colorcon, Inc
- Croda International Plc
- Dfe Pharma
- Evonik Industries Ag
- Fmc Corporation
- J Rettenmaier & Söhne Gmbh & Co Kg
- Lubrizol Corporation
- Meggle Ag
- The Dow Chemical Company
For more information visit http://www.researchandmarkets.com/research/7rkbj7/pharmaceutical
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets